Search results

Found 7,478 pages
AUTHOR: Selina McKee

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Takeda eyes up Shire

Takeda has revealed that it is considering making a move on Shire to add ballast to its core therapeutic areas. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/takeda_eyes_up_shire_1229776

AstraZeneca sheds Seroquel rights

AstraZeneca has sold off certain rights to its antipsychotics Seroquel and Seroquel XR in certain territories - including the UK – to Luye Pharma. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/astrazeneca_sheds_seroquel_rights_1234663

US regulators reject Valeant’s Duobrii

The US Food and Drug Administration has rejected Valeant group Ortho Dermatologics’ plaque psoriasis therapy Duobrii. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/us_regulators_reject_valeants_duobrii_1240725

FDA rejects Amgen’s Parsabiv

US regulators have turned down Amgen's request to market Parsabiv for secondary hyperparathyroidism (sHPT). - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/fda_rejects_amgens_parsabiv_1110551

EU nod for Vifor’s Veltassa

European regulators have approved Vifor Pharma’s new potassium binder Veltassa to treat hyperkalaemia in adult patients. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/eu_nod_for_vifors_veltassa_1199011

Roche rejoins APBI

Swiss drugs giant Roche is rejoining the Association of the British Pharmaceutical Industry after cutting ties with the trade body seven years ago. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/roche_rejoins_apbi_1119375

GW completes Epidiolex submission

GW Pharmaceuticals and its US subsidiary Greenwich Biosciences have completed the rolling submission of Epidiolex as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two difficult-to-treat forms of childhood-onset epilepsy. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/gw_completes_epidiolex_submission_1209905

Takeda ups its offer for Shire

Takeda has put forward a new proposed bid for Shire, increasing the cash portion of the deal. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/takeda_ups_its_offer_for_shire_1232830

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download